The latest research from Fore Pharma, Global Gastro-Intestinal Stromal Tumors Market and Competitive Landscape – 2020, provides comprehensive insights into Gastro-Intestinal Stromal Tumors pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Gastro-Intestinal Stromal Tumors market size and drug sales. It also provides insights into Gastro-Intestinal Stromal Tumors epidemiology and late stage pipeline.
This research covers the following – Gastro-Intestinal Stromal Tumors treatment options, Gastro-Intestinal Stromal Tumors late stage clinical trials pipeline, Gastro-Intestinal Stromal Tumors prevalence by countries, Gastro-Intestinal Stromal Tumors market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Gastro-Intestinal Stromal Tumors pipeline: Find out drugs in clinical trials for Gastro-Intestinal Stromal Tumors by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Gastro-Intestinal Stromal Tumors epidemiology: Find out number of patients diagnosed (prevalence) with Gastro-Intestinal Stromal Tumors by countries
– Gastro-Intestinal Stromal Tumors drugs: Identify key drugs marketed and prescribed for Gastro-Intestinal Stromal Tumors by countries, including trade name, molecule name, and company
– Gastro-Intestinal Stromal Tumors drugs sales: Find out the sales value for Gastro-Intestinal Stromal Tumors drugs by countries
– Gastro-Intestinal Stromal Tumors market valuations: Find out the market size for Gastro-Intestinal Stromal Tumors drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Gastro-Intestinal Stromal Tumors drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Gastro-Intestinal Stromal Tumors drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Gastro-Intestinal Stromal Tumors market
– Develop in-depth knowledge of competition and markets
– Analyze Gastro-Intestinal Stromal Tumors drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Gastro-Intestinal Stromal Tumors market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Gastro-Intestinal Stromal Tumors Treatment Options
2. Gastro-Intestinal Stromal Tumors Pipeline Insights
2.1. Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trials
2.2. Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trials
2.3. Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trials
3. Gastro-Intestinal Stromal Tumors Epidemiology Analysis by Countries
4. US Gastro-Intestinal Stromal Tumors Market Insights
4.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in US
4.2. US Gastro-Intestinal Stromal Tumors Market Size & Forecast
4.3. US Gastro-Intestinal Stromal Tumors Drugs Sales & Forecast
4.4. US Gastro-Intestinal Stromal Tumors Market Share Analysis
5. Germany Gastro-Intestinal Stromal Tumors Market Insights
5.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in Germany
5.2. Germany Gastro-Intestinal Stromal Tumors Market Size & Forecast
5.3. Germany Gastro-Intestinal Stromal Tumors Drugs Sales Forecast
5.4. Germany Gastro-Intestinal Stromal Tumors Market Share Analysis
6. France Gastro-Intestinal Stromal Tumors Market Insights
6.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in France
6.2. France Gastro-Intestinal Stromal Tumors Market Size & Forecast
6.3. France Gastro-Intestinal Stromal Tumors Product Sales Forecast
6.4. France Gastro-Intestinal Stromal Tumors Market Share Analysis
7. Italy Gastro-Intestinal Stromal Tumors Market Insights
7.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in Italy
7.2. Italy Gastro-Intestinal Stromal Tumors Market Size & Forecast
7.3. Italy Gastro-Intestinal Stromal Tumors Product Sales Forecast
7.4. Italy Gastro-Intestinal Stromal Tumors Market Share Analysis
8. Spain Gastro-Intestinal Stromal Tumors Market Insights
8.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in Spain
8.2. Spain Gastro-Intestinal Stromal Tumors Market Size & Forecast
8.3. Spain Gastro-Intestinal Stromal Tumors Product Sales Forecast
8.4. Spain Gastro-Intestinal Stromal Tumors Market Share Analysis
9. UK Gastro-Intestinal Stromal Tumors Market Insights
9.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in UK
9.2. UK Gastro-Intestinal Stromal Tumors Market Size & Forecast
9.3. UK Gastro-Intestinal Stromal Tumors Product Sales Forecast
9.4. UK Gastro-Intestinal Stromal Tumors Market Share Analysis
10. Europe Gastro-Intestinal Stromal Tumors Market Insights
10.1. Europe Gastro-Intestinal Stromal Tumors Market Size & Forecast
10.2. Europe Gastro-Intestinal Stromal Tumors Product Sales Forecast
10.3. Europe Gastro-Intestinal Stromal Tumors Market Share Analysis
11. Japan Gastro-Intestinal Stromal Tumors Market Insights
11.1. Marketed Drugs for Gastro-Intestinal Stromal Tumors in Japan
11.2. Japan Gastro-Intestinal Stromal Tumors Market Size & Forecast
11.3. Japan Gastro-Intestinal Stromal Tumors Product Sales Forecast
11.4. Japan Gastro-Intestinal Stromal Tumors Market Share Analysis
12. Global Gastro-Intestinal Stromal Tumors Market Insights
12.1. Global Gastro-Intestinal Stromal Tumors Market Size & Forecast
12.2. Global Gastro-Intestinal Stromal Tumors Product Sales Forecast
12.3. Global Gastro-Intestinal Stromal Tumors Market Share Analysis
13. Research Methodology
List of Tables
1: Gastro-Intestinal Stromal Tumors Phase 3 Clinical Trials, Global, 2020
2: Gastro-Intestinal Stromal Tumors Phase 2 Clinical Trials, Global, 2020
3: Gastro-Intestinal Stromal Tumors Phase 1 Clinical Trials, Global, 2020
4: Gastro-Intestinal Stromal Tumors Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Gastro-Intestinal Stromal Tumors in US, 2019
6: US Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
7: US Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
8: US Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Gastro-Intestinal Stromal Tumors in Germany, 2019
10: Germany Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
11: Germany Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
12: Germany Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Gastro-Intestinal Stromal Tumors in France, 2019
14: France Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
15: France Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
16: France Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Gastro-Intestinal Stromal Tumors in Italy, 2019
18: Italy Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
19: Italy Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
20: Italy Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Gastro-Intestinal Stromal Tumors in Spain, 2019
22: Spain Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
23: Spain Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
24: Spain Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Gastro-Intestinal Stromal Tumors in UK, 2019
26: UK Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
27: UK Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
28: UK Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
29: Europe Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
30: Europe Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Gastro-Intestinal Stromal Tumors in Japan, 2019
32: Japan Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
33: Japan Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
34: Japan Gastro-Intestinal Stromal Tumors Market Events and Trends, 2016 – 2025
35: Global Gastro-Intestinal Stromal Tumors Market Size & Forecast ($mn), 2016 – 2025
36: Global Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
List of Figures
1: Gastro-Intestinal Stromal Tumors Pipeline by Phase (%), Global, 2020
2: Gastro-Intestinal Stromal Tumors Prevalence by Countries, 2016 – 2025
3: US Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
4: US Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
5: US Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
6: US Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
7: Germany Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
8: Germany Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
9: Germany Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
10: Germany Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
11: France Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
12: France Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
13: France Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
14: France Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
15: Italy Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
16: Italy Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
17: Italy Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
18: Italy Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
19: Spain Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
20: Spain Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
21: Spain Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
22: Spain Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
23: UK Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
24: UK Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
25: UK Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
26: UK Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
27: Europe Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
28: Europe Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
29: Europe Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
30: Europe Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
31: Japan Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
32: Japan Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
33: Japan Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
34: Japan Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
35: Global Gastro-Intestinal Stromal Tumors Market Size ($mn), 2016 – 2025
36: Global Gastro-Intestinal Stromal Tumors Product Sales ($mn), 2016 – 2025
37: Global Gastro-Intestinal Stromal Tumors Market Share by Drugs (%), 2019
38: Global Gastro-Intestinal Stromal Tumors Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.